MIF Gene

Last updated on: 09.04.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The MIF gene (MIF stands for "Macrophage Migration Inhibitory Factor") is a protein-coding gene located on chromosome 22q11.23.

General informationThis section has been translated automatically.

The MIF gene encodes a pro-inflammatory lymphokine involved in cell-mediated immunity, immune regulation and inflammation. The lymphokine "Macrophage Migration Inhibitory Factor" plays a role in regulating macrophage function in host defense by suppressing the anti-inflammatory effects of glucocorticoids. It is thus involved in the innate immune response to bacterial pathogens (Calandra T et al 2003). The MIF protein and JAB1 protein form a complex in the cytosol near the peripheral plasma membrane, which may indicate an additional role in integrin signaling pathways. Macrophage migration inhibitory factor has phenylpyruvate tautomerase and dopachrome tautomerase activity (in vitro). However, the physiological substrate is not known.

Diseases associated with MIF include rheumatoid arthritis, systemic juvenile arthritis, and systemic onset juvenile idiopathic arthritis. Anti-MIF pharmacotherapies could also be steroid-sparing in patients with chronic glucocorticoid dependence or refractory autoimmune disease (Bilsborrow JB et al. 2019).

LiteratureThis section has been translated automatically.

  1. Bilsborrow JB et al (2019) Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus. Expert Opin Ther Targets. 23: 733-744.
  2. Calandra T et al (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3: 791-800.
  3. Kim KW et al (2016) Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritis. Korean J Intern Med 31: 634-642.

Last updated on: 09.04.2022